Renaissance Group »

Halozyme Therapeutics shares owned by Renaissance Group

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Renaissance Group from 13F filings

Historical chart of Renaissance Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Renaissance Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Renaissance Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $35M 479k 73.34

More positions owned by Renaissance Group

Applovin Corp Com Cl A (APP)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Arista Networks Com Shs (ANET)
Emcor (EME)
Meta Platforms Cl A (META)
Apple (AAPL)
Comfort Systems USA (FIX)
Amphenol Corp Cl A (APH)
Netflix (NFLX)
Kla Corp Com New (KLAC)
Applied Materials (AMAT)
Amazon (AMZN)
Cadence Design Systems (CDNS)

View all positions for Renaissance Group

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics